Celine Sakran

PhD Candidate at the Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto.

[Canadian Concussion Centre @UHNconcussions]

🧠 Join us for the CCC 12th Annual Concussion Research Symposium on May 23, 2025 – hybrid event (Zoom + Toronto).
Learn from top experts in concussion care.
✅ CPD-accredited by Royal College.
Register: https://t.co/TNUiJDSNAj
#Concussion #BrainHealth #CPD #UHN

[Alzheimer's Association @alzassociation]

The FDA has cleared the first blood test to aid in diagnosing Alzheimer's.

While there is still no stand-alone test to diagnose Alzheimer’s today, this FDA action marks an important step toward people obtaining an accurate diagnosis more quickly and earlier in the disease process, which is important now that there are treatments for early Alzheimer's. https://t.co/auZUXl5M0l

[University Health Network @UHN]

Dr. @MC_Tartaglia is shining a spotlight on precision medicine for neurodegenerative diseases. As a leading clinician-scientist at the UHN Memory Clinic, she and her team aim to transform how we understand, diagnose, and treat dementia.

Learn more:
https://t.co/SetmuRg4fe

[Canadian Concussion Centre @UHNconcussions]

Did you know brain injuries can increase your dementia risk? Listen to Baycrest’s #DefyDementia podcast for an inspiring story of brain injury recovery, and learn about the latest research on this topic. Tune in at https://t.co/ELW33oRQcs, or anywhere you get your podcasts.

[Celine Sakran @CelineSakran]

Temerty-Tanz-TDRA Workshop starting off with some wise words from Vince; his incredible reflection of Lived Experience with Research, Caregiving and Living with Mild Cognitive Impairment @TorontoDementia

[Celine Sakran @CelineSakran]

Feeling of relief after submitting your first doctoral grant. Now just waiting patiently for results 😬

[Cambridge FTD @CambridgeFTD]

Great to see ⁦@mrccbu⁩ and ⁦@CambridgeFTD⁩ ‘s old friend Luca Passamonti discussing biomarkers in support of therapeutics at #Neuro2024 ⁦@CurePSP⁩ - now at the “other Cambridge”

[The PhD Place @ThePhDPlace]

Go get that PhD.

[CarmelaTartaglia @MC_Tartaglia]

Congrats @JuanCVargasG for exposing that informant characteristics affect the CDR-SB, the primary end-point of AD trials https://t.co/qN68HuNVpE

[CurePSP @CurePSP]

@M_Malpetti's research focuses on in vivo biomarkers for inflammation, tau and synaptic loss to study primary tauopathies, frontotemporal dementia and related disorders. #Neuro2024

[Celine Sakran @CelineSakran]

@indi_gc @CurePSP Congrats @indi_gc!!

[Celine Sakran @CelineSakran]

@MC_Tartaglia @CurePSP @Neuro2024 Congrats on your breaking research @CAnastassiadis !!

[Celine Sakran @CelineSakran]

Thanks for having me @CurePSP 🧠 There were so many amazing insights on the assessment and progression of PSP & CBD that will continue to enhance future research and clinical applications #NEURO2024

[Celine Sakran @CelineSakran]

Day 2 at @CurePSP 🙌🏼 so many interesting discussions about the assessment of tau in Progressive Supranuclear Palsy and the future directions of clinical trials #NEURO2024

[CurePSP @CurePSP]

We are excited to be gathered in Toronto, Canada, for the PSP and CBD International Research Symposium. Today marks the start of insightful discussions and presentations on groundbreaking research in the field. Join the conversation and share your insights using #Neuro2024!

[Celine Sakran @CelineSakran]

Exciting day in Toronto at CurePSP 🧠

[CarmelaTartaglia @MC_Tartaglia]

@CelineSakran presenting great work on agitation @CurePSP #Neuro2024

[Celine Sakran @CelineSakran]

@indi_gc Thanks Indira!!

[Indira Garcia Cordero @indi_gc]

Congrats!!

[Celine Sakran @CelineSakran]

@MC_Tartaglia @isftd Thanks Dr. Tartaglia!